Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 1.00 |
| ▸ | CA6 | P23280 | 5/20 | 1.00 |
| ▸ | CA7 | P43166 | 5/20 | 1.00 |
| ▸ | CA9 | Q16790 | 5/20 | 1.00 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 1.00 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 1.00 |
| ▸ | CA2 | P00918 | 4/20 | 1.00 |
| ▸ | CA4 | P22748 | 4/20 | 1.00 |
| ▸ | CA5A | P35218 | 4/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
| ▸ | CA3 | P07451 | 3/20 | 1.00 |
| ▸ | F13A1 | P00488 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | THPO | P40225 | 2/20 | 1.00 |
| ▸ | CA1 | P00915 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | PKM | P14618 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | MTOR | P42345 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.93 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3165201 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| Spermidine SCHEMBL8073115 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| Spermidine SCHEMBL288987 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| SCHEMBL3175232 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| Spermine SCHEMBL288605 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| Spermine SCHEMBL5802297 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| Spermidine SCHEMBL15618 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| Spermidine SCHEMBL6253721 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| SCHEMBL4861043 | 0.97 | CA12 (0.93) | CA12CA6CA7CA9CA14 | |
| Spermidine SCHEMBL573651 | 0.97 | LMNA (1.00) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011019722-A2 | WATER-BASED MUD LUBRICANT USING FATTY ACID POLYAMINE SALTS AND FATTY ACID ESTERS | BAKER HUGHES INCORPORATED (US) | 2011-02-17 | — | — | WO | claimed |
| US-6413775-B1 | INHIBITING CELL GROWTH BY INDUCING SPERMIDINE SPERMINE N1 ACETYLTRANSFERASE MRNA BY TRANSFECTING CELLS WITH CDNA UNDER CONTROL OF A PROMOTER | HEALTH RESEARCH, INC. | 2002-07-02 | — | — | US | claimed |
| EP-4687900-A2 | COMBINATION TREATMENT FOR OVARIAN CANCER | The Johns Hopkins University (US) | 2026-02-11 | — | — | EP | disclosed |
| US-20250101518-A1 | METHODS OF DETECTING DISEASES OR CONDITIONS USING PHAGOCYTIC CELLS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2025-03-27 | — | — | US | disclosed |
| WO-2025054048-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING LIPID AND CHOLESTEROL METABOLISM ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | MarvelBiome, Inc. (US) | 2025-03-13 | — | — | WO | disclosed |
| US-20250057906-A1 | BROCCOLI EXTRACT, NUTRACEUTICAL, AND METHODS OF TREATING INFLAMMATION AND CANCER | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2025-02-20 | — | — | US | disclosed |
| CN-118891052-A | Lactobacillus acidophilus to increase agmatine production by microbiota | 雀巢产品有限公司 | 2024-11-01 | — | — | CN | disclosed |
| WO-2024211398-A2 | COMBINATION TREATMENT FOR OVARIAN CANCER | THE JOHNS HOPKINS UNIVERSITY (US) | 2024-10-10 | — | — | WO | disclosed |
| EP-4440342-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING VAGUS NERVE ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | MarvelBiome, Inc. (US) | 2024-10-09 | — | — | EP | disclosed |
| EP-4303584-A2 | METHODS FOR DETECTING SIGNATURES OF DISEASE OR CONDITIONS IN BODILY FLUIDS | President and Fellows of Harvard College (US) | 2024-01-10 | — | — | EP | disclosed |
| JP-2023101023-A | ACQUISITION METHOD, COMPUTATION METHOD, EVALUATION DEVICE, COMPUTATION DEVICE, EVALUATION PROGRAM, COMPUTATION PROGRAM, AND EVALUATION SYSTEM | 味の素株式会社 | 2023-07-19 | — | — | JP | disclosed |
| US-5906996-A | Tetramine treatment of neurological disorders | MURPHY MICHAEL A (US) | 1999-05-25 | — | — | US | disclosed |
| WO-1999008519-A1 | POLYAMINE TREATMENT OF NEUROLOGICAL DISORDERS | MURPHY MICHAEL A (US) | 1999-02-25 | — | — | WO | disclosed |
| EP-0876327-A2 | POLYAMINE TRANSPORT INHIBITORS | UNIVERSITE LAVAL (CA) | 1998-11-11 | — | — | EP | disclosed |
| EP-0871774-A1 | DETECTION OF NUCLEIC ACIDS AND NUCLEIC ACID UNITS | UNIVERSITY OF STRATHCLYDE (GB) | 1998-10-21 | — | — | EP | disclosed |
| WO-1998017623-A2 | POLYAMINE TRANSPORT INHIBITORS | UNIVERSITE LAVAL (US) | 1998-04-30 | — | — | WO | disclosed |
| EP-0785793-A1 | ALLOSTERIC MODULATORS OF THE NMDA RECEPTOR | Bearsden Bio, Inc. (US) | 1997-07-30 | — | — | EP | disclosed |
| WO-1997005280-A1 | DETECTION OF NUCLEIC ACIDS AND NUCLEIC ACID UNITS | UNIVERSITY OF STRATHCLYDE (GB) | 1997-02-13 | — | — | WO | disclosed |
| WO-1996011698-A1 | ALLOSTERIC MODULATORS OF THE NMDA RECEPTOR | SYMPHONY PHARMACEUTICALS, INC. (US) | 1996-04-25 | — | — | WO | disclosed |
| US-4376116-A | TREATMENT OF CYSTIC FIBROSIS AND PARASITIC INFECTIONS | RESEARCH CORPORATION (US) | 1983-03-08 | — | — | US | disclosed |